Sponsor Pipeline

Altimmune, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT06987513
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment…		 Trial completed
2026-08-01 NCT06987513
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment…		 Primary endpoint(s) modified
2026-08-01 NCT06987513
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment…		 date change Primary completion pushed: 2026-05 -> 2026-07-30
2026-08-01 NCT06987513
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment…		 date change Completion pushed: 2026-06 -> 2026-07-30
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07009860 RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the… Alcohol Liver Disease Recruiting
Get alerts when Altimmune, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free